I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Treatment status and safety of crizotinib in 2028 Japanese ..:
Ueno, Naomi
;
Banno, Shigeo
;
Endo, Yutaka
...
Japanese Journal of Clinical Oncology. 49 (2019) 7 - p. 676-686 , 2019
Link:
https://doi.org/10.1093/jjco/hyz049
RT Journal T1 <Title>Treatment status and safety of crizotinib in 2028 Japanese patients with ALK-positive NSCLC in clinical settings</Title> UL https://suche.suub.uni-bremen.de/peid=cr-10.1093_jjco_hyz049&Exemplar=1&LAN=DE A1 Ueno, Naomi A1 Banno, Shigeo A1 Endo, Yutaka A1 Tamura, Motoko A1 Sugaya, Katsuko A1 Hashigaki, Satoshi A1 Ohki, Emiko A1 Yoshimura, Akinobu A1 Gemma, Akihiko PB Oxford University Press (OUP) YR 2019 SN 1465-3621 JF Japanese Journal of Clinical Oncology VO 49 IS 7 SP 676 OP 686 LK http://dx.doi.org/https://doi.org/10.1093/jjco/hyz049 DO https://doi.org/10.1093/jjco/hyz049 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)
